UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 28
- Registration Number
- NCT04297605
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Video-based Detection of Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2023-01-27
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 256
- Registration Number
- NCT04267133
- Locations
- 🇺🇸
Strong Memorial Hospital, Rochester, New York, United States
Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 39
- Registration Number
- NCT04243512
- Locations
- 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States
Silverlon to Reduce Radiation Dermatitis
- First Posted Date
- 2020-01-23
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 31
- Registration Number
- NCT04238728
- Locations
- 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States
Memory and Attention Adaptation Training-Geriatrics (MAAT-G)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 4
- Registration Number
- NCT04230941
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
OptiVol for Precision Medical Management of Heart Failure
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 7
- Registration Number
- NCT04206501
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Risperidone for the Treatment of Huntington's Disease Involuntary Movements
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 5
- Registration Number
- NCT04201834
- Locations
- 🇺🇸
URMC Neurology; 919 Westfall Rd, Building C, Suite 100, Rochester, New York, United States
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2022-08-22
- Lead Sponsor
- University of Rochester
- Registration Number
- NCT04200066
Sexual & Gender Minority Competency in Oncology
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 62
- Registration Number
- NCT04198090
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention
- First Posted Date
- 2019-12-11
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 171
- Registration Number
- NCT04194489
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
© Copyright 2024. All Rights Reserved by MedPath